Back

First in human study BIOMAG-I: 12 months results of the sirolimus eluting resorbable coronary magnesium scaffold system (DREAMS 3G) in the treatment of subjects with de novo coronary artery lesions

25 August 2023 (07:30 - 18:30)
Organised by: Logo
Congress Presentation Part of: Acute coronary syndromes in clinical practice: miscellaneous Clinical ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Professor Michael Haude

Rheinland hospital, Neuss (Germany)

5 More presentations in this session

Presentation thumbnail
Diagnostic performance of bedside transthoracic echocardiography in the management of patients with suspected myocardial infarction
Doctor A. Schock (Hamburg, DE)
Abstract Slides Video
Presentation thumbnail
Right ventricular-pulmonary artery coupling and in-hospital mortality of patients with first acute coronary syndrome
Doctor V. Anastasiou (London, GB)
Abstract Slides Video
Presentation thumbnail
Consensus on the diagnosis and management of patients with type 2 myocardial infarction: an international Delphi study
Doctor C. Taggart (Edinburgh, GB)
Abstract Slides Video
Presentation thumbnail
Differences on left ventricular remodeling between patients with or without myocardial viability after late recanalization after STEMI: a matched quasi-experimental design.
Doctor B. Valente (Sao Paulo, BR)
Abstract Slides Video
Presentation thumbnail
Prevalence and prognostic impact of myocardial injury following hypertensive crisis
Doctor N. Soerensen (Hamburg, DE)
Abstract Slides Video

Access the full session

Session thumbnail
Acute coronary syndromes in clinical practice: miscellaneous

The Event

Event poster

ESC Congress 2023

25 August - 28 August 2023
You may be interested in
thumbnail
Congress Presentation
Ten-year major clinical outcomes between first- and second-generation Drug-Eluting Stents in unstable angina patients underwent Percutaneous Coronary Intervention
thumbnail
Congress Presentation
Biolimus A9 DEB for the Treatment of In-Stent Restenosis. 1-year outcomes of the REFORM trial.
thumbnail
Congress Presentation
Preclinical assessment of transcatheter-delivered expandable endoluminal polymeric graft fabricated by electrospinning of microfiber

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources